Valuation: Oxford BioDynamics Plc

Market Cap 17.66M 19.68M 16.33M 14.79M 27.62M 1.87B 27.96M 195M 77.75M 981M 73.85M 72.3M 3.11B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 21.29M 23.73M 19.68M 17.83M 33.31M 2.26B 33.71M 235M 93.74M 1.18B 89.05M 87.17M 3.75B EV / Sales 2026 *
11.3x
EV / Sales 2027 * -
Free-Float
90.64%
Yield 2026 *
-
Yield 2027 * -
1 day-6.38%
Current month-9.09%
1 month-9.09%
3 months-15.38%
6 months-50.00%
Current year-48.84%
1 week 0.1
Extreme 0.1
0.12
1 month 0.09
Extreme 0.09
0.12
Current year 0.08
Extreme 0.08
0.34
1 year 0.08
Extreme 0.08
0.34
3 years 0.08
Extreme 0.08
38.8
5 years 0.08
Extreme 0.08
52
10 years 0.08
Extreme 0.08
278.82
Manager TitleAgeSince
Chief Executive Officer - 30/06/2026
Chief Tech/Sci/R&D Officer 64 08/06/2007
Director of Finance/CFO - 15/09/2017
Director TitleAgeSince
Director/Board Member 64 08/06/2007
Director/Board Member - 15/09/2017
Director/Board Member 65 05/04/2019
Date Insider Type Main position Quantity % Market Cap. Importance
10/11/25 Free

Founder

15,000,000 0.7663%
10/11/25 Free

Executive/Senior Manager

15,000,000 0.7663%
10/11/25 Free

Chief Operating Officer

15,000,000 0.7663%
Change 5-day change 1-year change 3-year change Capi.($)
-6.38%0.00%-65.08%-99.68% 20.93M
+0.79%+1.79%+57.72%+128.65% 1,143B
+0.93%+5.23%+45.11%+84.49% 647B
-0.03%+0.52%+25.81%+101.76% 506B
-0.05%+1.73%+52.74%+65.27% 384B
-0.55%-6.16%+61.61%+36.98% 350B
+0.34%+1.84%+30.70%+52.69% 293B
-0.45%+1.19%+2.89%+24.92% 265B
+0.89%+2.99%+54.56%+71.53% 242B
+0.09%+3.74%+35.15%+104.85% 197B
Average -0.47%+1.44%+30.12%+57.15% 402.76B
Weighted average by Cap. +0.34%+0.71%+44.68%+87.21%

Financials

2026 *2027 *
Net sales 1.89M 2.11M 1.75M 1.58M 2.96M 201M 2.99M 20.9M 8.33M 105M 7.91M 7.74M 333M -
Net income - -
Net Debt 3.63M 4.05M 3.36M 3.04M 5.68M 386M 5.75M 40.16M 16M 202M 15.2M 14.87M 641M -
Projected Income Statement - Annual - Oxford BioDynamics Plc
Logo Oxford BioDynamics Plc
Oxford BioDynamics Plc is a United Kingdom-based biotechnology company, advancing personalized healthcare by developing and commercializing precision clinical diagnostic tests for life-changing diseases. The Company is primarily engaged in the commercialization of proprietary molecular diagnostics products and biomarker research and development. Its products include EpiSwitch CiRT, EpiSwitch PSE, Specimen Submission Kit, and EpiSwitch Explorer. The EpiSwitch CiRT is a blood test which predicts an individual patient’s therapeutic response to checkpoint inhibitor immunotherapy. The EpiSwitch Explorer is a microarray kit for high-throughput, high-resolution 3D genome profiling. The Specimen Submission Kit is used for collecting samples from any location. The EpiSwitch platform offers reproducibly translating three-dimensional (3D) genome regulation for clinical applications. This platform provides a portfolio of clinical smart tests based on EpiSwitch technology.
Employees
-
Date Price Change Volume
29/10/26 GBX 0.1100 -6.38% 15,886,210
27/10/26 GBX 0.1170 0.00% 27,056,478
26/10/26 GBX 0.1170 +1.74% 11,518,328
23/10/26 GBX 0.1150 +4.55% 166,017,541
22/10/26 GBX 0.1100 0.00% 74,588,762
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.001170GBP
Average target price
0.003000GBP
Spread / Average Target
+156.41%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Oxford BioDynamics Plc